PhenoPath

Seattle, United States Founded: 1998 • Age: 28 yrs Acquired By Quest Diagnostics
Standalone pathology lab

About PhenoPath

PhenoPath is a Healthcare company based in Seattle (United States) founded in 1998, and was acquired by Quest Diagnostics in September 2018. Standalone pathology lab. Its focus areas include Clinical Laboratories and Pathology. Its legal entity is PhenoPath, PLLC.

Company details

PhenoPath was established in 1998 as a standalone pathology laboratory in Seattle, United States. Diagnostic testing and pathology services are provided to healthcare providers and patients. Operations focus on specialized anatomic and molecular pathology within the medical diagnostics sector. The company maintains its headquarters in the Pacific Northwest, serving regional and national clients through its domain, phenopath.com. Independent lab functions are emphasized without affiliation to larger health systems.

Operational Areas
Key Metrics

Investors in PhenoPath

PhenoPath has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Quest Diagnostics.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Integrated diagnostic and IT services are provided to healthcare organizations.
1967questdiagnostics.comMadison, United States
Premium access

Investor details for PhenoPath

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of PhenoPath

2 dated milestones of PhenoPath across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded PhenoPath is founded.
  2. Exit Acquired by Quest Diagnostics.

Web traffic of PhenoPath

The website of PhenoPath (phenopath.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 19.5% vs previous month

Similar websites

Websites whose visitors overlap most with PhenoPath. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nephropathology-esp.org
nephropathology-esp.org
100%
–
unipathllc.com
unipathllc.com
99%
–
e-immunohistochemistry.info
e-immunohistochemistry.info
98%
–
incresearch.com
68%
View details
cellnetix.com
62%
#3,097,432View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 10 similar websites and full traffic analytics for PhenoPath

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 10 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diagnostics Laboratories

2 companies that operate in the same segment as PhenoPath (Diagnostics Laboratories) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Radiology centers are operated as a nationwide chain.
1984Los Angeles, California, United StatesUSD 2.04 B8,550
Chain of radiology centers
2015Jacksonville, United StatesUSD 749.63 M5,486
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about PhenoPath

PhenoPath was founded in 1998.

PhenoPath is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

PhenoPath was established in 1998 as a standalone pathology laboratory in Seattle, United States. Diagnostic testing and pathology services are provided to healthcare providers and patients. Operations focus on specialized anatomic and molecular pathology within the medical diagnostics sector. The company maintains its headquarters in the Pacific Northwest, serving regional and national clients through its domain, phenopath.com. Independent lab functions are emphasized without affiliation to larger health systems.

PhenoPath has 1 investor. Key investors include Quest Diagnostics.

PhenoPath operates through Phenopath, Pllc.

Yes. PhenoPath was acquired by Quest Diagnostics in September 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available